Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients with Appendiceal Mucinous Neoplasm with Peritoneal Dissemination

Diseases of the Colon and Rectum

Volumn 60, Issue 4, 2017, Pages 360-367

  Huang, Yeqian ^a   Alzahrani, Nayef A ^a,b   Chua, Terence C ^c   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b AL IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY IMSIU   (Saudi Arabia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Appendix cancer; Histology; Peritoneal dissemination; Prognosis

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MITOMYCIN; MUCIN; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADOLESCENT; ADULT; AGED; APPENDICEAL MUCINOUS NEOPLASM; APPENDIX CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CYTOREDUCTIVE SURGERY; FEMALE; HISTOLOGY; HOSPITAL MORTALITY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OVERALL SURVIVAL; PERITONEUM METASTASIS; POST TREATMENT SURVIVAL; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; VERY ELDERLY; ADENOCARCINOMA, MUCINOUS; APPENDICEAL NEOPLASMS; COHORT ANALYSIS; MIDDLE AGED; MORTALITY; PARENTERAL DRUG ADMINISTRATION; PATHOLOGY; PERITONEAL NEOPLASMS; PROGNOSIS; SECONDARY; SURVIVAL RATE; THERMOTHERAPY; YOUNG ADULT;

ADENOCARCINOMA, MUCINOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; APPENDICEAL NEOPLASMS; COHORT STUDIES; CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 85015405330     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000719     Document Type: Article

References (17)

1. Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome Lancet Oncol. 2006;7:69-76.
2. Chua TC, Moran BJ, Sugarbaker PH, et al. Early-and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449-2456.
3. Ihemelandu C, Sugarbaker PH. Clinicopathologic and prognostic features in patients with peritoneal metastasis from mucinous adenocarcinoma, adenocarcinoma with signet ring cells, and adenocarcinoid of the appendix treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23:1474-1480.
4. E nblad M, Birgisson H, Wanders A, Sköldberg F, Ghanipour L, Graf W. Importance of absent neoplastic epithelium in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23:1149-1156.
5. Carr NJ, Cecil TD, Mohamed F, et al.; Peritoneal Surface Oncology Group International. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;40:14-26.
6. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359-374.
7. S ugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29-42.
8. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
9. L am JY, McConnell YJ, Rivard JD, Temple WJ, Mack LA . Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis. Am J Surg. 2015;210:424-430.
10. T uraga KK, Pappas SG, Gamblin T. Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol. 2012;19:1379-1385.
11. I hemelandu C, Sugarbaker PH. Clinicopathologic and prognostic features in patients with peritoneal metastasis from mucinous adenocarcinoma, adenocarcinoma with signet ring cells, and adenocarcinoid of the appendix treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2015:1-7.
12. Glehen O, Mohamed F, Sugarbaker PH. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg. 2004;240:278-285.
13. Jacquet P, Sugarbaker P. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 1996;15:49-58.
14. Jimenez W, Sardi A, Nieroda C, et al. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21:4218-4225.
15. McCusker ME, Coté TR, Clegg LX, Sobin LH. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer. 2002;94:3307-3312.
16. L ieu CH, Lambert LA , Wolff RA, et al. Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol. 2012;23:652-658.
17. Davison JM, Choudry HA, Pingpank JF, et al. Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol. 2014;27:1521-1539.